Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

800 patients to help monitor hip implant safety for 15 years

NCT ID NCT05966220

Knowledge-focused Sponsor: FH ORTHO Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 800 adults who have received FH ORTHO hip implants during surgery. The goal is to collect real-world data on how long the devices last and how safe they are over up to 15 years. Participants will report their outcomes through simple online tools, helping doctors improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2024

Expected to finish

Dec 2038

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Any patient undergoing or having undergone implantation of medical devices distributed by FH ORTHO Company for hip arthroplasty and traumatology, used in accordance with their approved Instruction For Use, in one of the centers participating in the Observatory. 2. Patient is at least 18 years of age. 3. Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally). 4. In some countries, such as France, the patient will have to be socially insured to be included in the study. Exclusion Criteria: 1. An infection, or latent infection. 2. A mental or neuromuscular disorder that would create an unacceptable risk of prosthetic instability, failure of prosthetic fixation, or post-operative complications (except for the HIP\&GO Double mobility cemented cup and, if applicable, the associated stems and heads when assembled together). 3. Known Insufficient bone quality and/or bone stock. 4. Known allergy to any component of the material listed on the product label. 5. Metabolic diseases that could compromise bone regrowth. 6. Metabolic and/or vascular treatment or disease that may compromise bone healing or consolidation. 7. Drug dependency. 8. Uncooperative patient unable to follow recommendations. 9. Protected adult

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier Du Haut Bugey

    RECRUITING

    Oyonnax, 01 100, France

  • Clinique Mutualiste La Sagesse

    RECRUITING

    Rennes, 35 043, France

  • Clinique Pasteur

    RECRUITING

    Guilherand-Granges, 07 500, France

  • Clinique de l'Atlantique

    RECRUITING

    Saint-Herblain, 44 800, France

  • Polyclinique Reims-Courlancy

    RECRUITING

    Reims, 51 100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.